Endocrinology & Metabolic Syndrome
Open Access
ISSN: 2161-1017
ISSN: 2161-1017
Esin KAVURAN Esra YILDIZ
RN, Ataturk University, Erzurum, Turkey
Posters & Accepted Abstracts: Endocrinol Metab Syndr
Aim: The aim of this study was to investigate the reliability and validity of the Turkish version of the Diabetes Fatalism Scale (DFS), which was developed by Egede. Materials and methods: This was a methodological study. The scales were administered to a total of 152 patients with type 2 diabetes. The content and construct validity of the scale were assessed. The construct validity was evaluated using confirmatory factor analysis (CFA), and the reliability was assessed in terms of internal consistency. Results: In terms of the population tested, 54% of the participants were men, 73.4% were married, 75% had another disease, 25% were high school graduates, the average age was 50.20 ± 16.82 years, the average duration of diabetes was 19.31 ± 14.25, and mean hemoglobin A1C (HgA1C) level was 7.06 ± 0.65. It was found that the Kaiser-Meyer-Olkin (KMO) measure of sampling-size adequacy was 0.770, indicating an adequate size, and the chi-square value was 1078.402. When the fifth item was excluded from the study and the analysis was repeated, the KMO coefficient was 0.802 and the chi-square value was 1020.244, p = 0.000. The Cronbach's alpha value reached 0.806, indicating a good internal consistency. The Cronbach's alpha values of the other subscales also seemed to be at a very good level. Conclusion: Our study showed that the DFS is a valid and reliable scale for the Turkish society. DFS-T is a suitable scale for health professionals to use to assess the fatalism of diabetic patients in Turkey. Key Words: Diabetes, fatalism, nursing, reliability, validity, Turkish